Cellular Dynamics Files for IPO Targeting $57.3M | GenomeWeb

NEW YORK (GenomeWeb News) – Stem cell technologies company Cellular Dynamics International today announced it has filed with the US Securities and Exchange Commission to go public.

The Madison, Wis.-based firm filed its Form S-1 with SEC on Monday, saying it plans on an initial public offering to raise a maximum aggregate amount of $57.3 million. The price range for its shares and the number of shares to be offered have not been determined.

JP Morgan Securities is the sole book-running manager on the offering, while Cowen and Co. and Leerink Swann are co-managers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.